Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to ...
GoodRx reports Medicaid work requirements for adults in 40 states will begin Jan. 1, 2027, potentially causing 5 million to ...
Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.
Antitrust activity, which made headlines in 2025 with high profile cases, will continue in 2026 as new laws and leadership ...
Possible implications of TrumpRx, the federal Direct-To-Consumer sales channel, are starting to emerge ahead of its scheduled launch next year. It has been reported that prescription drug savings ...
GlobalData on MSN
JP Morgan 2025: GoodRx takes aim at US drug pricing challenges
At the 2025 JP Morgan Healthcare Conference, GoodRx’s recently appointed CEO Wendy Barnes highlighted the company’s strategic ...
Drexel takes into consideration a number of criteria when determining admission, including your high school performance, letters of recommendation, standardized test scores, and essay. Students are ...
Everyday Health on MSN
Zepbound vs. Wegovy: Which obesity treatment might be right for you?
Wegovy and Zepbound are two FDA-approved weight loss drugs. Learn how they compare in benefits, side effects, and more to ...
Access detailed historical stock prices, including daily closing prices, for GDRX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results